A significant study conducted in South Korea and Japan has revealed an increased risk of various neuropsychiatric conditions in individuals suffering from long COVID. The research, which analyzed data from 10 million people in Japan and 12 million in South Korea, identified a pronounced rise in cases of Guillain-Barré syndrome, cognitive deficits, insomnia, anxiety disorders, encephalitis, ischemic stroke, and mood disorders among long COVID patients. The study, published in NatureHumBehav, also noted that vaccination reduced the incidence of these conditions. The findings underscore the long-term mental and neurological effects of COVID-19, highlighting the need for ongoing monitoring and intervention strategies.
Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan https://t.co/WQC4WCx78R 1/5
A super important study published today. They looked at 10 million people in Japan and 12 million in South Korea. The long-term risk of neuropsychiatric events following COVID-19 was higher than the risk in both the general population and those with another respiratory… https://t.co/7yBMvtHbrH https://t.co/CSGUJRaKmP
A non medical summary of Dr. Sanjeev’s post. Short and long-term mental and neurological effects of long COVID have been studied in South Korea and Japan. These effects include: - Guillain-Barré syndrome: A rare condition where the immune system attacks the nerves, causing… https://t.co/5xJlI4mw2O
Short-& long-term neuropsychiatric outcomes in long COVID in S.Korea & Japan; range of conditions: Guillain-Barré syndrome, cognitive deficit, insomnia, anxiety disorder, encephalitis, ischaemic stroke, mood disorder exhib⬆️⬆️in long-term risk. https://t.co/Z6NW68Y4yX
A huge study of #LongCovid in South Korea and Japan shows a pronounced increase of Guillain-Barré syndrome, cognitive deficit, insomnia, anxiety disorder, encephalitis, ischemic stroke and mood disorder. Reduced by vaccination https://t.co/XEztk0KJsg @NatureHumBehav https://t.co/unt4QGX5Ob